ITCI |
Intra-Cellular Therapies, Inc. |
Sep 30, 2024 |
1 |
$18K |
4 |
Oct 2, 2024 |
Director |
CBUS |
Cibus, Inc. |
Sep 18, 2024 |
1 |
$1M |
4 |
Sep 20, 2024 |
Chief Executive Officer, Director, 10%+ Owner |
ITCI |
Intra-Cellular Therapies, Inc. |
Jun 28, 2024 |
1 |
$17.9K |
4 |
Jul 2, 2024 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Jun 23, 2024 |
5 |
$6.66 |
4 |
Jun 25, 2024 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Jun 14, 2024 |
2 |
$0 |
4 |
Jun 18, 2024 |
Director |
CBUS |
Cibus, Inc. |
Jun 11, 2024 |
2 |
$1M |
4 |
Jun 14, 2024 |
Chief Executive Officer, Director, 10%+ Owner |
ITCI |
Intra-Cellular Therapies, Inc. |
Mar 31, 2024 |
1 |
$18K |
4 |
Apr 2, 2024 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Mar 20, 2024 |
2 |
$371K |
4 |
Mar 22, 2024 |
Director |
RPRX |
Royalty Pharma plc |
Feb 20, 2024 |
2 |
$0 |
4 |
Feb 22, 2024 |
Director |
RPRX |
Royalty Pharma plc |
Jan 2, 2024 |
3 |
-$13.2M |
4 |
Jan 4, 2024 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Dec 31, 2023 |
1 |
$18K |
4 |
Jan 3, 2024 |
Director |
CBUS |
Cibus, Inc. |
Dec 29, 2023 |
5 |
$0 |
4 |
Jan 3, 2024 |
Chief Executive Officer, Director, 10%+ Owner |
CBUS |
Cibus, Inc. |
Dec 12, 2023 |
3 |
$6M |
4 |
Dec 14, 2023 |
Chief Executive Officer, Director, 10%+ Owner |
RPRX |
Royalty Pharma plc |
Nov 13, 2023 |
2 |
$0 |
4 |
Nov 14, 2023 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Sep 30, 2023 |
1 |
$18K |
4 |
Oct 2, 2023 |
Director |
RPRX |
Royalty Pharma plc |
Aug 8, 2023 |
1 |
$0 |
4 |
Aug 8, 2023 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Jun 30, 2023 |
1 |
$17.7K |
4 |
Jul 5, 2023 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Jun 23, 2023 |
2 |
$0 |
4 |
Jun 27, 2023 |
Director |
RPRX |
Royalty Pharma plc |
Jun 23, 2023 |
1 |
$0 |
4 |
Jun 26, 2023 |
Director |
CBUS |
Cibus, Inc. |
May 31, 2023 |
0 |
$0 |
4/A |
Jun 15, 2023 |
Chief Executive Officer, Director, 10%+ Owner |
CBUS |
Cibus, Inc. |
May 31, 2023 |
0 |
$0 |
3 |
Jun 2, 2023 |
Chief Executive Officer, Director |
RPRX |
Royalty Pharma plc |
May 22, 2023 |
1 |
-$57.4M |
4 |
May 22, 2023 |
Director |
RPRX |
Royalty Pharma plc |
May 9, 2023 |
2 |
$0 |
4 |
May 12, 2023 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Mar 31, 2023 |
1 |
$16.9K |
4 |
Apr 4, 2023 |
Director |
RPRX |
Royalty Pharma plc |
Mar 29, 2023 |
2 |
-$5.08M |
4 |
Mar 30, 2023 |
Director |
RPRX |
Royalty Pharma plc |
Feb 17, 2023 |
2 |
$0 |
4 |
Feb 17, 2023 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Dec 30, 2022 |
1 |
$17K |
4 |
Jan 3, 2023 |
Director |
RPRX |
Royalty Pharma plc |
Dec 9, 2022 |
2 |
-$2.52M |
4 |
Dec 13, 2022 |
Director |
RPRX |
Royalty Pharma plc |
Nov 17, 2022 |
1 |
-$5.08M |
4 |
Nov 21, 2022 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Sep 30, 2022 |
1 |
$17K |
4 |
Oct 4, 2022 |
Director |
RPRX |
Royalty Pharma plc |
Sep 14, 2022 |
2 |
-$4.23M |
4 |
Sep 15, 2022 |
Director |
RPRX |
Royalty Pharma plc |
Aug 9, 2022 |
1 |
-$1.97M |
4 |
Aug 11, 2022 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Jun 30, 2022 |
1 |
$16.5K |
4 |
Jul 5, 2022 |
Director |
RPRX |
Royalty Pharma plc |
Jun 29, 2022 |
1 |
-$1.27M |
4 |
Jun 29, 2022 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Jun 9, 2022 |
1 |
$0 |
4 |
Jun 13, 2022 |
Director |
RPRX |
Royalty Pharma plc |
May 19, 2022 |
2 |
-$5.91M |
4 |
May 23, 2022 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Mar 31, 2022 |
1 |
$15.7K |
4 |
Apr 4, 2022 |
Director |
RPRX |
Royalty Pharma plc |
Mar 29, 2022 |
1 |
-$2.32M |
4 |
Mar 30, 2022 |
Director |
RPRX |
Royalty Pharma plc |
Mar 17, 2022 |
10 |
-$6.67M |
4 |
Mar 21, 2022 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Mar 16, 2022 |
6 |
-$13.6M |
4 |
Mar 18, 2022 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Dec 31, 2021 |
1 |
$15.7K |
4 |
Jan 4, 2022 |
Director |
RPRX |
Royalty Pharma plc |
Dec 28, 2021 |
9 |
-$7.4M |
4 |
Dec 30, 2021 |
Director |
RPRX |
Royalty Pharma plc |
Nov 16, 2021 |
10 |
-$9.08M |
4 |
Nov 18, 2021 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Sep 30, 2021 |
1 |
$15.7K |
4 |
Oct 4, 2021 |
Director |
RPRX |
Royalty Pharma plc |
Sep 28, 2021 |
12 |
-$4.69M |
4 |
Sep 30, 2021 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Jun 30, 2021 |
1 |
$15.7K |
4 |
Jul 2, 2021 |
Director |
RPRX |
Royalty Pharma plc |
Jun 25, 2021 |
5 |
-$55.4M |
4 |
Jun 29, 2021 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Jun 21, 2021 |
1 |
$0 |
4 |
Jun 22, 2021 |
Director |
RPRX |
Royalty Pharma plc |
Jun 7, 2021 |
1 |
$12.4M |
4 |
Jun 8, 2021 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
May 27, 2021 |
2 |
$0 |
4 |
Jun 4, 2021 |
Director |
FGEN |
FIBROGEN INC |
May 26, 2021 |
2 |
$0 |
4 |
May 28, 2021 |
Director |
RPRX |
Royalty Pharma plc |
May 7, 2021 |
4 |
$0 |
4 |
May 11, 2021 |
Director |
ITCI |
Intra-Cellular Therapies, Inc. |
Jun 18, 2019 |
2 |
$0 |
4 |
Oct 15, 2024 |
Director |